OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Neurology is 75. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Diplopia and Ptosis in an Older Woman	516
Somebody to Love	493
Optimizing the Time Course of Risks and Benefits of Acute Dual Antiplatelet Therapy for Stroke Prevention	381
Itching Frequency and Neuroanatomic Correlates in Frontotemporal Lobar Degeneration	380
Risk of Dementia in Individuals With Emergency Department Visits or Hospitalizations Due to Cannabis	235
Error in Author Name	230
Early Posttraumatic Seizures—Putting Things in Perspective	229
A Call to Action to Address Sex Differences in Alzheimer Disease Clinical Trials	226
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation	220
Origin of Transthyretin in Cerebral Amyloid Angiopathy	217
Ghrelin for Neuroprotection in Post–Cardiac Arrest Coma	212
Equipping AI for Unbiased and Inclusive Neurology	211
Early Access to First-Seizure Clinics, Subsequent Outcomes, and Factors Associated With Attendance	211
Rizatriptan vs Placebo for Attacks of Vestibular Migraine	211
Automated Imaging Differentiation for Parkinsonism	210
Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation	191
Substantia Nigra Pathology, Contact Sports Play, and Parkinsonism in Chronic Traumatic Encephalopathy	190
Alternate Hemibody Hyperkinetic and Hypokinetic Movement Disorders Due to Strategic Lesions in Cerebral Toxoplasmosis	181
Magnetic Resonance Imaging Features of Tropical Candidal Meningoencephalitis	179
Reinterpreting Clinical Trials in Children With Multiple Sclerosis Using a Bayesian Approach	175
JAMA Neurology	161
Thrombolysis With Tenecteplase for Minor Disabling Stroke	157
Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease	155
Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers	154
JAMA Neurology	151

The Neurologist’s Imperative in Brain Death	144
Is It Really Itching?	144
Teleneurorehabilitation and Motor and Nonmotor Symptoms and Quality of Life in Parkinson Disease	141
External Carotid Artery Angioplasty Based on Ultrahigh-Resolution Photon-Counting CTA	135
Time to Change the Current Clinical Classification of Multiple Sclerosis?	134
Anticoagulation and Antiplatelet Therapy in Patients With Atrial Fibrillation and Atherosclerosis	132
Time From Hospital Arrival Until Endovascular Thrombectomy and Patient-Reported Outcomes in Acute Ischemic Stroke	126
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis	124
Functional Outcomes in Conservatively vs Surgically Treated Cerebellar Infarcts	120
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation	119
Error in Abstract	116
Do Neurologists Need a Goldwater Rule?	116
Disentangling Workflow Paradigms and Treatment Decision-making in Acute Ischemic Stroke	109
Histologic Anatomy of Neurocysticercosis	106
Error in Figure	105
Error in Additional Contributions	104
Spontaneous AICA Dissection Presenting With Isolated Audiovestibular Loss	102
Error in Figure	100
Functional Seizures—A Critical Comorbidity Overlooked in Epilepsy Research—Reply	99
Is It Really Itching?—Reply	99
Sleep Recording for the Diagnosis and Treatment of Paraplegia	99
Spinal Cerebrospinal Fluid Leak Mimicking a Cerebellopontine Angle Tumor	99
Association of Cardiovascular Events With Spouse’s Subsequent Dementia	99
Endovascular Stroke Thrombectomy for Patients With Large Ischemic Core	98
β-Amyloid Positron Emission Tomography Use Across Medicare Administrative Contractor Regions	98
JAMA Neurology	98
Retinal Hemorrhage Associated with Human Granulocytic Anaplasmosis	95
Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease	94
Seizure Frequency Trends Over Time in Treatment-Resistant Focal Epilepsy	94
Tackling the Unmet Therapeutic Needs in Nonsurgical Treatments for Epilepsy	92
Interhemispheric Bullet Migration—A Surgical Dilemma	91
N-Acetylcysteine for Hereditary Cystatin C Amyloid Angiopathy	89
Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment	88
Prourokinase vs Standard Care for Patients With Mild Ischemic Stroke	88
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum	87
Noncontrast Computed Tomography vs Computed Tomography Perfusion or Magnetic Resonance Imaging Selection in Late Presentation of Stroke With Large-Vessel Occlusion	86
Wind Swirl Pattern on Density Spectral Array in Anti-GABAB Receptor Encephalitis With Amnestic Seizures	85
Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy	85
Intra-Arterial Tenecteplase After Successful Reperfusion in Large Vessel Occlusion Stroke	84
GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias	82
Role of the X Chromosome in Alzheimer Disease Genetics	82
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease	80
Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology	80
JAMA Neurology	78
Error in Text	77
JAMA Neurology	77
Acute Myelopathy in a Man With Cutaneous Papules	76
Perceived CTE and Suicidality—Is Perception Reality?	76
Peripheral-Type Facial Paralysis and Unilateral Hemisphere Hemorrhage	75
Error in Figures	75

Behavioral Compared With Drug Therapy for Overactive Bladder Symptoms in Parkinson Disease	75
Error in Key for Figure 3	75